# Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy

> **NCT00280761** · — · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 47 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** 5-fluorouracil
- **PROCEDURE:** Surgical Resection
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT00280761
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2021-09-19
- **Final completion:** 2021-09-19
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280761, "Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00280761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*